Biocartis Group NV
Biocartis Group NV (BCART.BR) Stock Competitors & Peer Comparison
See (BCART.BR) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Diagnostics & Research Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BCART.BR | €0.29 | +0.00% | 27.2M | -0.32 | -€0.92 | N/A |
| BIM.PA | €125.60 | +2.95% | 14.8B | 34.51 | €3.64 | +0.72% |
| ERF.PA | €65.90 | +4.01% | 11.6B | 29.03 | €2.27 | +0.91% |
| LBIRD.PA | €18.45 | +0.27% | 406.1M | 70.96 | €0.26 | N/A |
| ALECR.PA | €17,800.00 | +0.00% | 89.8M | 12.55 | €1,418.66 | N/A |
| MDXH.BR | €3.02 | -3.76% | 85.6M | -1.58 | -€1.91 | N/A |
| ALBIO.PA | €1.24 | +0.40% | 22.6M | -0.37 | -€3.33 | N/A |
| ALPRE.PA | €3.54 | +7.27% | 13.3M | -2.97 | -€1.19 | N/A |
| EEP.MC | €0.54 | N/A | 6.3M | -54.00 | -€0.01 | N/A |
| MLAHC.PA | €0.60 | +0.00% | 5.4M | -10.00 | -€0.06 | N/A |
Stock Comparison
BCART.BR vs BIM.PA Comparison July 2025
BCART.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BCART.BR stands at 27.2M. In comparison, BIM.PA has a market cap of 14.8B. Regarding current trading prices, BCART.BR is priced at €0.29, while BIM.PA trades at €125.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BCART.BR currently has a P/E ratio of -0.32, whereas BIM.PA's P/E ratio is 34.51. In terms of profitability, BCART.BR's ROE is +2.04%, compared to BIM.PA's ROE of +0.11%. Regarding short-term risk, BCART.BR is less volatile compared to BIM.PA. This indicates potentially lower risk in terms of short-term price fluctuations for BCART.BR.Check BIM.PA's competition here